☆ 4.7 Editorial Material

From resveratrol to ISIDE11: how to activate SIRT1 and improve endothelial function? New therapeutic insights for methylenetetrahydrofolate reductase deficiency

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Related references

Note: Only part of the references are listed.

Article Biochemistry & Molecular Biology

SIRT1 pharmacological activation rescues vascular dysfunction and prevents thrombosis in MTHFR deficiency

Albino Carrizzo et al.

Summary: In addition to well-known risk factors, cardiovascular events may also be associated with epigenetic and genetic alterations. This study found that the MTHFR C677T gene variant is related to increased cardiovascular risk. Interestingly, even with normal homocysteine levels, heterozygous carriers of this gene variant have an augmented risk of cardiovascular accidents, suggesting the presence of additional deregulated processes. The study suggests that targeting SIRT1 activation could be a new therapeutic strategy to control cardiovascular risk in MTHFR carriers.

CELLULAR AND MOLECULAR LIFE SCIENCES (2022)

Add to Collection

Article Nutrition & Dietetics

Methylenetetrahydrofolate (MTHFR), the One-Carbon Cycle, and Cardiovascular Risks

Shanel Raghubeer et al.

Summary: The MTHFR enzyme plays a crucial role in cellular homeostasis and its polymorphisms, especially C677T, are associated with various diseases including cardiovascular diseases. The C677T polymorphism leads to elevated Hcy levels and is considered an independent risk factor for CVD.

NUTRIENTS (2021)

Add to Collection

Article Pediatrics

Association betweenMTHFRC677T/A1298C and susceptibility to autism spectrum disorders: a meta-analysis

Yan Li et al.

BMC PEDIATRICS (2020)

Add to Collection

Article Clinical Neurology

A common risk variant in the MTHFR gene contributes to age‐related cerebrovascular dysfunction in VCID

Alaina M. Reagan et al.

Alzheimers & Dementia (2020)

Add to Collection

Article Multidisciplinary Sciences

Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration

Francesco Parmeggiani et al.

SCIENTIFIC REPORTS (2019)

Add to Collection

Review Psychiatry

Methylenetetrahydrofolate reductase and psychiatric diseases

Lin Wan et al.

TRANSLATIONAL PSYCHIATRY (2018)

Add to Collection

Review Nutrition & Dietetics

Resveratrol and Cardiovascular Diseases

Dominique Bonnefont-Rousselot

NUTRIENTS (2016)

Add to Collection

Article Medicine, Research & Experimental

A selective microRNA-based strategy inhibits restenosis while preserving endothelial function

Gaetano Santulli et al.

JOURNAL OF CLINICAL INVESTIGATION (2014)

Add to Collection

Editorial Material Clinical Neurology

Pearls & Oy-sters: Familial epileptic encephalopathy due to methylenetetrahydrofolate reductase deficiency

Gerarda Cappuccio et al.

NEUROLOGY (2014)

Add to Collection

Article Nutrition & Dietetics

Prospective study of methylenetetrahydrofolate reductase (MTHFR) variant C677T and risk of all-cause and cardiovascular disease mortality among 6000 US adults

Quanhe Yang et al.

AMERICAN JOURNAL OF CLINICAL NUTRITION (2012)

Add to Collection

Review Pharmacology & Pharmacy

Sirtuins and disease: the road ahead

Vincenzo Carafa et al.

FRONTIERS IN PHARMACOLOGY (2012)

Add to Collection

Article Cardiac & Cardiovascular Systems

Mthfr deficiency induces endothelial progenitor cell senescence via uncoupling of eNOS and downregulation of SIRT1

Catherine A. Lemarie et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2011)

Add to Collection

© Peeref 2019-2024. All rights reserved.